[{"from": "human", "value": "What can you tell me about this molecule? [C][C][C][N][Branch1][=Branch1][C][C][N][Ring1][=Branch1][C][=C][Branch2][Ring1][S][C][=C][C][=Branch1][=Branch1][=C][Ring1][=Branch1][O][C][N][Branch1][=C][C][=C][Branch1][Branch1][C][Ring1][=Branch2][=O][C][=Branch1][C][=O][O][C][C][C][Ring1][Ring1][F]"}, {"from": "gpt", "value": "The molecule is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial enzymes DNA gyrase and topoisomerase IV. Bristol-Myers Squibb introduced Gatifloxacin in 1999 under the proprietary name Tequin&#8482; for the treatment of respiratory tract infections, having licensed the medication from Kyorin Pharmaceutical Company of Japan. Allergan produces an eye-drop formulation called Zymar&#8482;. Gatifloxacin is available as tablets and in various aqueous solutions for intravenous therapy. [Wikipedia]"}]